Trial · NCT07282340
Phentermine's Impact on Treatment in Teens
NCT07282340, Phase 2, Recruiting, Russell McCulloh, MD
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Phentermine's Impact on Treatment in Teens. Trials, record NCT07282340. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07282340
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Phentermine's Impact on Treatment in Teens
- NCT number
- NCT07282340
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 240 participants, estimated
- Lead sponsor
- Russell McCulloh, MD
- Conditions
- Childhood Obesity
- Interventions
- Phentermine, Placebo
- First posted
- 2025-12-15
- Last updated
- 2026-10-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change in BMI from Baseline at Week 52 | 52 weeks | Change in body mass index (BMI) expressed as a percentage of baseline BMI at week 52. |
| Secondary | Number of Treatment-Emergent Adverse Events (TEAEs) | 52 weeks | Count of TEAEs deemed probably or definitely related to study drug, including common side effects |
| Secondary | Number of Treatment-Emergent Adverse Events of Special Interest (TEAESIs) | 52 weeks | Count of TEAESIs deemed probably or definitely related to study drug, including tachycardia, hypertension, depression, suicidality, and withdrawal symptoms |
| Other | Changes in Cardiometabolic Risk Factor Waist Circumference | 52 weeks | Change in waist circumference from baseline |
| Other | Changes in Cardiometabolic Risk Factor Blood Pressure | 52 weeks | Change blood pressure from baseline |
| Other | Changes in Cardiometabolic Risk Factor Glucose | 52 weeks | Change in glucose from baseline |
| Other | Changes in Cardiometabolic Risk Factor Lipids | 52 weeks | Change in lipids from baseline |
| Other | Changes in Cardiometabolic Risk Factor Hemoglobin A1C | 52 weeks | Change in hemoglobin A1C from baseline |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| U24OD038400 | Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network | MAYO, MATTHEW S; MCCULLOH, RUSSELL JAMES; WICK, JO ADRIANNE | UNIVERSITY OF KANSAS MEDICAL CENTER | OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07282340
GET https://conductscience.org/api/trials/v1/NCT07282340/registered